kevin johnson, cih, csp, director ehs, siemens healthcare ... · page 11 10-nov-2015 turi ce...
TRANSCRIPT
Restricted © Siemens Healthcare GmbH 2015 Alle Rechte vorbehalten. Answers for life.
TURI Continuing Education Conference Proactive Chemicals Management
Kevin Johnson, CIH, CSP,
Director EHS, Siemens Healthcare Point of Care
10-Nov-2015 Page 2 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Siemens Healthcare – A “Company in the Company“
Managing Board
SFS MO
Europe,
AMfarirckaet Americas Middle
East, CIS 1)
Financial
Services
Mobility Energy
Manage-
ment 2)
EM
Building
Techno-
logies
BT
Digital
Factory
DF
Process
Industries
and Drives
PD
Healthcare
HC
Corporate Services
Siemens
Real Estate
SRE
Corporate Supply
Chain Management
CSCM
Information
Technology
IT
Global Shared
Services
GSS
1) Commonwealth of Independent States 2) Includes Siemens One 3) Includes Corporate Sustainability Office 4) Includes Corporate Security Office
Global Healthcare Asia,
Australia
Div
isio
ns (
Glo
ba
l P&
L)
Go
-to
-ma
rke
t
Separately managed
Power and
Gas
PG
Wind Power
and
Renewables
WP
Power Generation Services
PS
Corporate Governance Legal and Communications and Human Corporate Controlling
Corporate Core Development 3) & Markets 4) Compliance Government Affairs Resources Technology and Finance
CD GM LC CG HR CT CF
Middle
East, CIS1)
Europe,
Africa
10-Nov-2015 Page 3 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Facts & figures
Siemens Healthcare – A leading medical infrastructure company
2) FY 2014 external
revenue by location of
customer
3) Commonwealth of
Independent States
4) as of September 30, 2014 1) In FY 2014 adjusted for a positive effect related to the expected sale of a PT installation
Revenue
Profit (w/o PPA amortization)
in % of revenue
New Orders
Underlying Profit1)
in % of revenue
€ 12.1bn
€ 11.7bn
€ 2.1bn 17.7%
€ 2.0bn 17.0%
Key Financials Revenue by Region2)
Employees worldwide4)
43,000
FY
2014
FY
2013
42,000
FY
2012
42,000
FY
2011
42,000
FY
2010
40,000
FY 2014
Note: All data Healthcare excl. HS & AU
7%
28%
38%
Europe, CIS3),
Africa, Middle East
(Excl. Germany)
Americas
27%
Asia, Australia
Germany
10-Nov-2015 Page 4 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Delivering Solutions Across the Entire Clinical Spectrum
Radiation
therapy
Oncology
Neurology
Radiology
Emergency
Women‘s
health Urology
Cardiology
Surgery
Intensive
care unit
Laboratory
Interventional
angiography
Computed tomography
X-ray imaging
Mammography
Ultrasound imaging
Magnetic resonance
imaging
Molecular imaging
Hemostasis &
hematology testing
Imaging Software
Point of care testing Molecular testing
Clinical chemistry &
immunoassay testing
10-Nov-2015 Page 5 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Chemicals of Concern More prevalent than we thought
• Carcinogens
• Mutagens
• Reproductive toxins
• Persistent bioaccumulative toxins (and very persistent very bioaccumulative toxins)
• Endocrine disruptors
• Sensitizers
• Other substances of equivalent concern
10-Nov-2015 Page 6 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Key Drivers of Concern
EU REACH regulation:
• Diagnostics reagents are affected more severely
than articles.
• Some substances of very high concern (SVHC)
present major risks.
• Authorizations will result in bans on use of
important raw materials.
Other regulatory agencies:
• China (RoHS)
• Korea (RoHS, REACH)
Customer and NGO expectations:
• SVHCs
• Phthalates, BPA, energy, etc.
10-Nov-2015 Page 7 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Define chemicals of concern (CoC).
Identify presence in products and processes.
Rank “scientific” risks.
Determine business impacts.
Set priorities.
Risk Management Process
10-Nov-2015 Page 8 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Chemicals of Concern List
A collection of lists that represents a broad array of chemicals that “could” be an issue:
• Various global regulatory agency lists of chemicals of concern (EU, US, China, etc.).
• Non-governmental organizations (NGOs).
• Recognized reference sources (e.g. IARC, NTP, etc.).
10-Nov-2015 Page 9 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Identification in Products and Processes
Query material requirements planning (MRP) systems (e.g. SAP).
Extracts from product Safety Data Sheet (SDS) system.
Reviews by R&D and manufacturing.
Challenges often occur with trade name raw materials.
Difficulties with finding substance groups- what specific
substances are in or out of scope.
10-Nov-2015 Page 10 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Ranking of “Scientific” Risks
Conducted by EHS staff.
Based on known or estimated data.
Comprised of three areas:
• Subject of a Ban or a Restriction.
• Date of ban or restriction.
• Strength of data for listing as chemical of concern.
Summary of Scientific Data
Current target of
ban or
restriction? (Y/N)
[Ban= more
weight; restr=
med; none= low]
Effective
Date of ban
or restriction (Actual or
estimated date or
Unknown) [<5 yr=
High; 5-10yr=
Med; >10yr= Low]
Strength of
scientific
data [High;
Med; Low]
(medium weight)
10-Nov-2015 Page 11 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Business Impact Assessment
A combination of objective and subjective
impacts:
• Markets affected.
• Revenue impact.
• End of life projection.
• Technical importance of the substance.
• Availability of substitutes.
• Effort needed to qualify a substitute.
• Supply chain vulnerability.
• Other variables (e.g. manufacturing location).
10-Nov-2015 Page 12 Kevin Johnson /Siemens Healthcare POC Restricted TURI CE Conference
Prioritization and Next Steps
Specific actions identified by product management teams with input
from EHS.
Visibility up through Business leadership.
CoC review now an early stage deliverable in Product Development
Process (PDP):
• Emphasis on avoiding CoCs during new product development and
using risk assessment to aid in business decisions.
Kevin Johnson, CIH, CSP
Director EHS Siemens Healthcare Point of Care
Norwood, MA 02062 USA
+01-781-269-3893